WHO hopes for release of bird flu studies, prepares for second meeting on controversy

NewsGuard 100/100 Score

Keiji Fukuda, WHO assistant director-general for health security and environment, "is hoping bird flu studies currently in publishing limbo will be released by the time the agency hosts a second meeting on the controversy this summer," the Canadian Press/Winnipeg Free Press reports. "A major break in the impasse would be needed for that to happen," the Canadian Press writes, adding, "As things currently stand, revised versions of the two studies are due to be presented late this month to the U.S. biosecurity panel that earlier recommended against their full publication."

"The meeting of the National Science Advisory Board for Biosecurity is scheduled for March 29 and 30, sources say," the Canadian Press writes. "Fukuda ... says the WHO's second meeting on the studies and the challenging related issues they pose will take place regardless of the publication status of the papers at the time," the news service notes, adding, "Fukuda says the agency is still trying to figure out which and how many topics should be discussed at the summer meeting, and is considering opening that process up to outsiders" (Branswell, 3/16).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Promising influenza drug candidate shows activity against resistant variants